LINC01018

Across TCGA pan-cancer cohorts, LINC01018 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated LINC01018 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher LINC01018 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LINC01018 expression acts as an unfavorable survival marker, although some lineages such as ACC and LIHC show a favorable association.

ACC, LIHC, and BLCA are the cancer types where LINC01018 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Median	All	0.785	0.419	<.001	84	view →
LIHC	DFS	Tertile	All	0.614	0.441	.001	77	view →
BLCA	DFS	Median	All	0.235	0.453	.002	61	view →
HNSC	DFS	Median	IV	0.729	0.553	<.001	52	view →
UCEC	OS	Quartile	All	0.505	0.683	<.001	50	view →
DLBC	DFS	Quartile	III,IV	0.074	0.984	.008	39	view →
STAD	OS	Tertile	All	0.596	0.751	.001	37	view →
CHOL	OS	Quartile	II,III,IV	0.137	0.850	.002	25	view →
MESO	OS	Tertile	All	0.700	0.254	.019	18	view →
UCS	DFS	Median	III,IV	0.527	0.141	.002	18	view →
KIRP	DFS	Tertile	All	0.489	0.758	.008	18	view →
PRAD	DFS	Tertile	All	0.950	0.876	.013	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

LINC01018–ACC (OS)

Open the ACC breakdown →